期刊文献+

hOPG转染对大鼠BMSCs及种植体周围成骨的影响 被引量:2

Effect of hOPG Gene Transfection on Osteogenesis of Rat BMSCs and around Implant
下载PDF
导出
摘要 目的:研究体内、体外人骨保护素(hOPG)基因对大鼠骨髓间充质干细胞(BMSCs)成骨功能和种植体周围成骨的影响。方法:构建含hOPG的重组腺病毒,蛋白印迹杂交法Western Blot检测转染细胞OPG蛋白功能表达。倒置显微镜观察转染细胞形态差别,茜素红S染色鉴定转染细胞的体外成骨能力。建立大鼠股骨干骺端羟基磷灰石涂层种植体植入动物模型。植入种植体前,实验组于植入体窝注入10μL的病毒悬浮液;对照组注入10μL的PBS。4周后取材,HE染色,光镜下观察,定量分析。结果:Western blot结果显示OPG在蛋白水平高表达;茜素红S染色转染组和未转染组都出现了较多散在的致密圆形矿化结节,萃取染色后分光光度检测两者无明显差异;体内实验显示实验组种植体周围成骨明显高于对照组。结论:体外pDC316-hOPG-EGFP成功转染大鼠BMSCs,转染hOPG基因的BMSCs能持续稳定的高表达hOPG。转染不影响BMSCs的成骨活性。种植体周围注射hOPG具有促进种植体周围成骨的作用。 Objective: To study effect of hOPG gene transfection on osteogenic differentiation of rat BMSCs and osteogenesis around implant in vitro and in vivo. Methods: Recombinant adenovirus containing hOPG was constructed. PCR and western blot were used to detect the transcription of hOPG DNA and protein. We used inverted microscope to observe the transfection cell morphological differences and Alizarin red S staining to evaluate transfection cells in vitro osteogenesis ability. 10ul hOPG adenovirus was injected into defect around HA coating implant in experimental group, while the same volume PBS was used in control group. Osteogenesis was observed by HE staining 4 weeks after implantation. Results: Western blot results showed that hOPG adenovirus transfection improved expression of hOPG in protein level. In alizarin red S staining, two groups showed similar density of mineralized nodules and extraction spectrophotometric detection after dyeing. No difference could be found between the two groups. Osteogenesis in experimental group was more obvious than that in control group in vivo. Conclusion: AdS --hOPG--EGFP could be transfected into BMSCs and secret hOPG at a high level. Transfection dose of Ad5- hOPG--EGFP has no obvious effect on the osteogenic activity of BMSCs. OPG could improve osteogenesis around implant in vivo.
出处 《口腔医学研究》 CAS CSCD 2014年第6期514-518,共5页 Journal of Oral Science Research
基金 教育部新世纪优秀人才支持计划项目(编号:NCET-10-0597) 四川大学优秀青年学者基金(编号:2012SCU4A12)
关键词 骨保护素 骨髓间充质干细胞 成骨 基因转染 种植体 OPG BMSCs Osteogenesis Gene transfection Implant
  • 相关文献

参考文献12

  • 1Wu Y, Liu J, Guo H, et al. Int J Endocrinol. Establishment of OPG Transgenic Mice and the Effect of OPG on Bone Mi- croarehiteeture, 2013, 125932.
  • 2Mizuno A, Amizuka N, Irie K, et al. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprote- gerin[J].BiochemBiophys Res Commun, 1998, 247 (3) : 610-5.
  • 3Stolina M, Dwyer D, Ominsky MS, et al. Continuous RANKL inhibition in osteoprotegerintransgenic mice and rats suppresses bone resorptionwithout impairing lymphorgano- genesis or functional immune responses[J]. J Immunol, 2007, 179(11): 7497-505.
  • 4Li X, Liang L, Zhao P, et aL The effects of adenoviral transfection of the keratinocyte growth factor gene on epider- mal stem cells: An in vitro study [J]. Mol Cells, 2013, 36 (4) : 316-21.
  • 5Xue JX, Gong YY, Zhou GD, et al. Chondrogenic differenti-ation of bone marrow- derived mesenchymal stem cells in- duced by acellular cartilage sheets [J]. Biomaterials,2012,33 (24) : 5832-40.
  • 6Kang SW, Bae JH, Park SA, et al. Combination therapy with BMP- 2 and BMSCs enhances bone healing efficacy of PCL scaffold fabricated using the 3D plotting system in a large segmental defect model [J]. BiotechnolLett, 2012, 34 (7) : 1375-84.
  • 7Fukunaga J, Yamaai T, Yamachika E, et al. Expression of osteoclast differentiation factor and osteoclastogenesis inhibi- tory factor in rat osteoporosis induced by immunosuppressant FK506 [J]. Bone,2004,34(3) : 425-31.
  • 8Kwak SC, Lee C, Kim JY, et al. Chlorogenic Acid Inhibits Osteoclast Differentiation and Bone Resorption by Down- Regulation of Receptor Activator of Nuclear Factor Kappa-B Ligand-Induced Nuclear Factor of Activated T Cells c1 Ex- pression. Biol Pharm Buli,2013,36(11) : 1779-86.
  • 9Nakanishi A, Hie M, litsuka N, etal. A crucial role for re- active oxygen species in macrophage colony-stimulating fac tor-induced RANK expression in osteoclastiedifferentiation [J]. Int J MolMed, 2013,31(4) : 874-80.
  • 10Ozeki K, Okuyama Y, Fukui Y, et al. Bone response to tita- nium implants coated with thin sputtered HA film subject to hydrothermal treatment and implanted in the canine mandi- ble. Biomed Mater Eng, 2006, 16(4): 243-51.

同被引文献13

  • 1Baud'huin M, Lamoureux F, Duplomb L, et al. RANKL, RANK,osteoprotegerin: key partners of osteoimmunology and vascular diseases [J]. Cell Mol Life Sci,2007,64(18) : 2334-50.
  • 2Brendan F, Boyce M. D, Lianping Xing, et al. Functions of RANKL/RANK/OPG in bone modeling and Remodeling [J]. Arch Biochem Biophys,2008,473(2) : 139-46.
  • 3Lin JM, Callon KE, Lin CQ, et al. Alteration of bone cell func- tion by RANKL and OPG in different in vitro models [J]. Eur J Clin Invest,2007,37(5) : 407-15.
  • 4Habashneh R, Alehalabi H, Khader YS. Association be- tween periodontal disease and osteoporosis in postmenopaus- al women in jordan [J]. Periodontol,2010,81(11) : 1613- 1621.
  • 5Ajdukovie Z, Dimie A, Stankovic, et al. Mineral substances in the bone tissue and blood of patients with osteoporosis [J]. MedPregl,2009,62(9-10) : 402-406.
  • 6Persson GR, Berglund J, Persson RE, et al. Prediction of hip and hand fractures in older persons with or without a di- agnosis of periodontitis [J]. Bone, 2011, 48(3) : 552-556.
  • 7Suresh S,Kumar TS,Saraswathy PK, et al. Periodontitis and bone mineral density among pre and post menopausal women:A comparative study [J]. Indian Soe Periodontol, 2010, 14(1) : 30-34.
  • 8Ominsky MS, Stouch B, Schroeder J, et al. Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus mon- keys [J]. Bone, 2011, 49 (2) : 162-173.
  • 9Genant HK, Engelke K, Hanley DA, et al. Denosumab im- proves density and strength parameters as measured by QCT of the radius in postmenopausal women with low bone min- eral density [J]. Bone, 2010, 47(1) : 131-139.
  • 10Lin JM, Callon KE, Lin CQ, et al. Alteration of bone cell function by RANKL and OPG in different in vitro models [J]. Eur J ClinInvest, 2007, 37(5) : 407-415.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部